Seeking Alpha
More on ACUS by Mike Havrilla
Latest ACUS Articles
-
FDA Calendar Updates: Acusphere, AspenBio, Alkermes
May 19, 2009 • Mike Havrilla
-
Vanda Pharma: An Extreme FDA Trade That Paid; 9 More to Go
May 7, 2009 • Mike Havrilla
-
12 Extreme FDA Trades on New Product Decisions
April 9, 2009 • Mike Havrilla
-
Hedge Fund Portfolio Tracking: Seth Klarman's Baupost Group, Q4 2008
March 3, 2009 • Market Folly
-
Baupost Group (Seth Klarman): Portfolio Update
January 22, 2009 • Market Folly
-
Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
December 12, 2008 • Mike Havrilla
-
Biotech Update: Arena Pharmaceuticals, Acusphere, Cephalon, ViroPharma, Auxilium
November 3, 2008 • Zacks.com
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.










Acusphere, Inc. (ACUS)
Posts on ACUS by Mike Havrilla
FDA Calendar Update: Acusphere, Cephalon
An Extreme FDA Trade that Paid: Vanda Pharma (NASDAQ:VNDA)
Posts on ACUS by other instabloggers
Business Conferences - ACUS, HEB
FDA Watchlist - ACUS